Literature DB >> 9682378

Haemorrhagic septicaemia vaccines.

R Verma1, T N Jaiswal.   

Abstract

Haemorrhagic septicaemia (HS), an economically important disease of cattle and buffaloes, is caused by Pasteurella multocida (6:B). Vaccination against this disease is widely practised. Plain broth bacterins, or alum precipitated and aluminium hydroxide gel vaccines are administered twice a year since these vaccines offer an immunity of 4-6 months. Many countries use oil adjuvant vaccine (OAV), which gives both a higher degree and a longer duration of immunity up to 1 year. A double emulsion and multiple emulsion vaccine consisting of a thin viscosity have also been experimentally developed that gave an immunity parallel to OAV. Recently, a live vaccine developed from a fallow deer strain (B:3,4) has been used in Myanmar that offers an immunity for more than a year but is not free from constraints. The present review provides information on HS vaccines developed from time to time using whole bacteria or their components. The kinetics and isotype of antibody and cell-mediated immune responses have also been poorly understood so far, and hence information on their role in protection against HS is reviewed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682378     DOI: 10.1016/s0264-410x(98)80118-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Cloning and characterization of type 4 fimbrial gene (ptfA) of Pasteurella multocida serogroup B:2 (strain P52).

Authors:  J Siju; A A Kumar; S B Shivachandra; P Chaudhuri; S K Srivastava; V P Singh
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

2.  Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.

Authors:  Mark P Dagleish; J Christopher Hodgson; Saeed Ataei; Anna Finucane; Jeanie Finlayson; Jill Sales; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

3.  Pharmacokinetics, urinary excretion and plasma protein binding of danofloxacin following intravenous administration in buffalo calves (Bubalus bubalis).

Authors:  Ravinder Sappal; Rakesh Kumar Chaudhary; Harpal Singh Sandhu; Pritam Kaur Sidhu
Journal:  Vet Res Commun       Date:  2009-03-19       Impact factor: 2.459

4.  Evaluation of immuno efficiency of hemorrhagic septicemia vaccine strain (vaccine seed).

Authors:  Maheswarappa Gowrakkal; M Chandrashekar; Shankarappa Bhajantri; Jaykumar Satav; Gc Chandakala; Asha Mayanna; Sm Byregowda; C Renukaprasad
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

5.  Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.

Authors:  J Christopher Hodgson; Anna Finucane; Mark P Dagleish; Saeed Ataei; Roger Parton; John G Coote
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Development of OMP based indirect ELISA to gauge the antibody titers in bovines against Pasteurella multocida.

Authors:  V Dogra; S Verma; G Singh; A H Wani; R Chahota; P Dhar; L Verma; M Sharma
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

7.  Acapsular Pasteurella multocida B:2 can stimulate protective immunity against pasteurellosis.

Authors:  J D Boyce; B Adler
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Carboxyl terminus heterogeneity of type IV fimbrial subunit protein of Pasteurella multocida isolates.

Authors:  Sathish Bhadravati Shivachandra; Abhinendra Kumar; Revanaiah Yogisharadhya; M A Ramakrishnan; K N Viswas
Journal:  Vet Res Commun       Date:  2013-06-30       Impact factor: 2.459

9.  Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.

Authors:  Mohammad Tabatabaei; Zhiqi Liu; Anna Finucane; Roger Parton; John Coote
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 10.  Transboundary Animal Diseases, an Overview of 17 Diseases with Potential for Global Spread and Serious Consequences.

Authors:  Elizabeth A Clemmons; Kendra J Alfson; John W Dutton
Journal:  Animals (Basel)       Date:  2021-07-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.